BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19760920)

  • 1. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
    Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: association with metastatic potential and cell morphology.
    Guo Q; Tang W; Inagaki Y; Kokudo N; Sugawara Y; Karako H; Nakata M; Makuuchi M
    Oncol Rep; 2007 May; 17(5):1057-60. PubMed ID: 17390044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers.
    Inagaki Y; Xu H; Nakata M; Seyama Y; Hasegawa K; Sugawara Y; Tang W; Kokudo N
    Biosci Trends; 2009 Dec; 3(6):220-32. PubMed ID: 20103851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.
    Xu H; Inagaki Y; Tang W; Guo Q; Wang F; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2008; 55(88):2000-4. PubMed ID: 19260467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.
    Guo Q; Tang W; Inagaki Y; Midorikawa Y; Kokudo N; Sugawara Y; Nakata M; Konishi T; Nagawa H; Makuuchi M
    World J Gastroenterol; 2006 Jan; 12(1):54-9. PubMed ID: 16440417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion.
    Xu HL; Inagaki Y; Seyama Y; Sugawara Y; Kokudo N; Nakata M; Wang FS; Tang W
    Life Sci; 2009 Aug; 85(9-10):395-400. PubMed ID: 19631667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of osteopontin mRNA and its protein in colorectal cancer and liver metastatic tissues].
    Ding L; Zheng S; Cao J
    Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):970-3. PubMed ID: 12181091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
    Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
    Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mucin core protein of mammary type in primary liver cancer.
    Sasaki M; Nakanuma Y
    Hepatology; 1994 Nov; 20(5):1192-7. PubMed ID: 7523272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer.
    Miyagawa S; Soeda J; Takagi S; Miwa S; Ichikawa E; Noike T
    Hum Pathol; 2004 Nov; 35(11):1392-6. PubMed ID: 15668897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
    Salnikov AV; Kusumawidjaja G; Rausch V; Bruns H; Gross W; Khamidjanov A; Ryschich E; Gebhard MM; Moldenhauer G; Büchler MW; Schemmer P; Herr I
    Cancer Lett; 2009 Mar; 275(2):185-93. PubMed ID: 19026485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
    Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
    Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of osteopontin in colorectal cancer and liver metastatic tissues].
    Ding L; Zheng S
    Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):773-5. PubMed ID: 12487883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
    Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.